Kennedy adopts new chikungunya vaccine guidance, but other actions waitnews2025-05-16T02:05:29+00:00May 16th, 2025|Endpoints News|
Top RFK Jr. advisor dares drugmakers over threats to drop manufacturing promisesnews2025-05-15T22:36:16+00:00May 15th, 2025|Endpoints News|
Regeneron gets $400M+ jury win in Amgen cholesterol drug casenews2025-05-15T21:16:54+00:00May 15th, 2025|Endpoints News|
Eisai says Leqembi sales are expanding steadily in USnews2025-05-15T19:25:06+00:00May 15th, 2025|Endpoints News|
New CBER chief is readying ‘massive framework’ for vaccines, Makary saysnews2025-05-15T19:06:19+00:00May 15th, 2025|Endpoints News|
Bristol Myers CEO says America’s biopharma pole position is not guaranteednews2025-05-15T15:40:09+00:00May 15th, 2025|Endpoints News|
Empower Pharmacy allegedly used low-quality ingredients, skirted rulesnews2025-05-15T13:18:23+00:00May 15th, 2025|Endpoints News|
Merck KGaA Q1 earnings: Tariff surcharge for US customers will continuenews2025-05-15T11:03:52+00:00May 15th, 2025|Endpoints News|
Biohaven stock sinks on three-month delay for neuro drug’s FDA approval decisionnews2025-05-15T10:47:38+00:00May 15th, 2025|Endpoints News|
Hengrui, one of China’s leading biotechs, anticipates $1.2B in proposed Hong Kong listingnews2025-05-15T08:52:29+00:00May 15th, 2025|Endpoints News|
